Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-016793
Filing Date
2021-04-22
Accepted
2021-04-22 19:10:30
Documents
2
Period of Report
2021-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5666
2 EX-24 DOCUMENT attachment1.htm EX-24 3985
  Complete submission text file 0000899243-21-016793.txt   11013
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Therapeutics Inc. (Issuer) CIK: 0001724979 (see all company filings)

EIN.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address
Vellanki Avanish (Reporting) CIK: 0001856682 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40356 | Film No.: 21846229